|
1
|
Zhang ML, Peng P, Wu CX, Gong YM, Zhang
SW, Chen WQ and Bao PP: Report of breast cancer incidence and
mortality in China registry regions, 2008–2012. Zhonghua Zhong Liu
Za Zhi. 41:315–320. 2019.(In Chinese). PubMed/NCBI
|
|
2
|
He Y, Li D, Shan B, Liang D, Shi J, Chen W
and He J: Incidence and mortality of esophagus cancer in China,
2008–2012. Chin J Cancer Res. 31:426–434. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caballero Vázquez A, García Flores P,
Romero Ortiz A, Del Moral RG and Alcázar-Navarrete B: Changes in
non-small cell lung cancer diagnosis, molecular testing and
prognosis 2011–2016. J Thorac Dis. 10:5468–5475. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fernandez FG, Kosinski AS, Furnary AP,
Onaitis M, Kim S, Habib RH, Tong BC, Cowper P, Boffa D, Jacobs JP,
et al: Differential effects of operative complications on survival
after surgery for primary lung cancer. J Thorac Cardiovasc Surg.
155:1254–1264.e1. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mishra S, Yadav T and Rani V: Exploring
miRNA based approaches in cancer diagnostics and therapeutics. Crit
Rev Oncol Hematol. 98:12–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen R, Xu X, Qian Z, Zhang C, Niu Y, Wang
Z, Sun J, Zhang X and Yu Y: The biological functions and clinical
applications of exosomes in lung cancer. Cell Mol Life Sci.
76:4613–4633. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nigita G, Distefano R, Veneziano D, Romano
G, Rahman M, Wang K, Pass H, Croce CM, Acunzo M and Nana-Sinkam P:
Tissue and exosomal miRNA editing in non-small cell lung cancer.
Sci Rep. 8:102222018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Grisard E, Coan M, Cesaratto L, Rigo I,
Zandonà L, Paulitti A, Andreuzzi E, Rampioni Vinciguerra GL,
Poletto E, Del Ben F, et al: Sleeping beauty genetic screen
identifies miR-23b::BTBD7 gene interaction as crucial for
colorectal cancer metastasis. EBioMedicine. 46:79–93. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang T, He X, Chen A, Tan K and Du X:
LncRNA HOTAIR contributes to the malignancy of hepatocellular
carcinoma by enhancing epithelial-mesenchymal transition via
sponging miR-23b-3p from ZEB1. Gene. 670:114–122. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xian X, Tang L, Wu C and Huang L:
miR-23b-3p and miR-130a-5p affect cell growth, migration and
invasion by targeting CB1R via the Wnt/β-catenin signaling pathway
in gastric carcinoma. Onco Targets Ther. 11:7503–7512. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hattori A, Takamochi K, Oh S and Suzuki K:
New revisions and current issues in the eighth edition of the TNM
classification for non-small cell lung cancer. Jpn J Clin Oncol.
49:3–11. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cao M and Chen W: Epidemiology of lung
cancer in China. Thorac Cancer. 10:3–7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen W, Sun K, Zheng R, Zeng H, Zhang S,
Xia C, Yang Z, Li H, Zou X and He J: Cancer incidence and mortality
in China, 2014. Chin J Cancer Res. 30:1–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie Y, Zhang Y, Du L, Jiang X, Yan S, Duan
W, Li J, Zhan Y, Wang L, Zhang S, et al: Circulating long noncoding
RNA act as potential novel biomarkers for diagnosis and prognosis
of non-small cell lung cancer. Mol Oncol. 12:648–658. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Yin Z, Fan J, Zhang S and Yang W:
The roles of exosomal miRNAs and lncRNAs in lung diseases. Signal
Transduct Target Ther. 4:472019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rupaimoole R, Calin GA, Lopez-Berestein G
and Sood AK: miRNA deregulation in cancer cells and the tumor
microenvironment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gallach S, Jantus-Lewintre E,
Calabuig-Fariñas S, Montaner D, Alonso S, Sirera R, Blasco A, Usó
M, Guijarro R, Martorell M and Camps C: MicroRNA profiling
associated with non-small cell lung cancer: Next generation
sequencing detection, experimental validation, and prognostic
value. Oncotarget. 8:56143–56157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu S, Kong H, Hou Y, Ge D, Huang W, Ou J,
Yang D, Zhang L, Wu G, Song Y, et al: Two plasma microRNA panels
for diagnosis and subtype discrimination of lung cancer. Lung
Cancer. 123:44–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zaporozhchenko IA, Morozkin ES,
Ponomaryova AA, Rykova EY, Cherdyntseva NV, Zheravin AA,
Pashkovskaya OA, Pokushalov EA, Vlassov VV and Laktionov PP:
Profiling of 179 miRNA expression in blood plasma of lung cancer
patients and cancer-free individuals. Sci Rep. 8:63482018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang P, Yang D, Zhang H, Wei X, Ma T,
Cheng Z, Hong Q, Hu J, Zhuo H, Song Y, et al: Early detection of
lung cancer in serum by a panel of microRNA biomarkers. Clin Lung
Cancer. 16:313–319.e1. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen X, Xu Y, Liao X, Liao R, Zhang L, Niu
K, Li T, Li D, Chen Z, Duan Y and Sun J: Plasma miRNAs in
predicting radiosensitivity in non-small cell lung cancer. Tumour
Biol. 37:11927–11936. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Munagala R, Aqil F and Gupta RC: Exosomal
miRNAs as biomarkers of recurrent lung cancer. Tumour Biol.
37:10703–10714. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang J, Li S, Li L, Li M, Guo C, Yao J
and Mi S: Exosome and exosomal microRNA: Trafficking, sorting, and
function. Genomics Proteomics Bioinformatics. 13:17–24. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang YT, Huang YY, Zheng L, Qin SH, Xu XP,
An TX, Xu Y, Wu YS, Hu XM, Ping BH and Wang Q: Comparison of
isolation methods of exosomes and exosomal RNA from cell culture
medium and serum. Int J Mol Med. 40:834–844. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang ZF, Wang M and Xu JL: Thymidine
kinase 1 combined with CEA, Cyfra21-1 and NSE improved its
diagnostic value for lung cancer. Life Sci. 194:1–6. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Begum S, Hayashi M, Ogawa T, Jabboure FJ,
Brait M, Izumchenko E, Tabak S, Ahrendt SA, Westra WH, Koch W, et
al: An integrated genome-wide approach to discover deregulated
microRNAs in non-small cell lung cancer: Clinical significance of
miR-23b-3p deregulation. Sci Rep. 5:132362015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen D, Wu X, Xia M, Wu F, Ding J, Jiao Y,
Zhan Q and An F: Upregulated exosomic miR-23b-3p plays regulatory
roles in the progression of pancreatic cancer. Oncol Rep.
38:2182–2188. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wei DM, Dang YW, Feng ZB, Liang L, Zhang
L, Tang RX, Chen ZM, Yu Q, Wei YC, Luo DZ and Chen G: Biological
effect and mechanism of the miR-23b-3p/ANXA2 axis in pancreatic
ductal adenocarcinoma. Cell Physiol Biochem. 50:823–840. 2018.
View Article : Google Scholar : PubMed/NCBI
|
